Effects of paclitaxel coated balloon on efficacy,target vessel diameter,and MACE in elderly patients with coronary heart disease
Objective:To investigate the therapeutic effect of paclitaxel coated balloon on elderly patients with coronary heart disease,and its impact on target vessel diameter and cardiovascular adverse events(MACE).Method A total of 82 elderly patients with coronary heart disease admitted to Wuxi People's Hospital Affiliated to Nanjing Medical University from June 2020 to June 2022 were randomly divided into an observation group of 41 cases and a control group of 41 cases.The control group was treated with drug-eluting stents,while the observation group was treated with paclitaxel coated balloon(DCB).Compare the total effective rate,cardiac function indicators,target lesion lumen diameter and stenosis rate,and MACE incidence between two groups.Results After surgery,the total effective rate of the observation group(97.56％)was significantly higher than that of the control group(82.93％)(P＜0.05).The left ventricular ejection fraction(LVEF)and stroke volume(SV)in the observation group were significantly increased compared to before treatment(P＜0.05),and were significantly higher than those in the control group(P＜0.05).The stenosis rate of the target lesion lumen in the observation group was significantly decreased compared to before treatment(P＜0.05),and significantly lower than that in the control group(P＜0.05).The lumen diameter was significantly increased compared to before treatment(P＜0.05),and significantly larger than that in the control group(P＜0.05).The incidence of MACE in the observation group was significantly lower than that in the control group(P＜0.05).Conclusion The use of paclitaxel coated balloon therapy for elderly patients with coronary heart disease can effectively alleviate clinical symptoms,improve heart function,and reduce the incidence of MACE.It is worth promoting in clinical practice.
万方数据
